Review
Copyright ©2013 Baishideng Publishing Group Co.
World J Immunol. Jul 27, 2013; 3(2): 18-30
Published online Jul 27, 2013. doi: 10.5411/wji.v3.i2.18
Table 2 Common clinical associations of paraproteins[70]
Disorder Diagnostic features
Monoclonal gammopathy of undetermined significanceAll three criteria must be met:
Serum monoclonal protein < 30 g/L
Clonal bone marrow plasma cells < 10%
Absence of end-organ damage ("CRAB"), e.g., hypercalcemia, renal insufficiency, anaemia and bone lesions due to the plasma cell disorder
Smouldering myelomaBoth criteria must be met:
Serum monoclonal protein (IgG or IgA) > 30 g/L and/or clonal bone marrow plasma cells > 10%
Absence of "CRAB", as defined above
Multiple myelomaAll three criteria must be met:
Clonal bone marrow plasma cells > 10%
Presence of serum and/or urinary monoclonal protein (except in patients with true non-secretory multiple myeloma)
Evidence of "CRAB", as defined above
Waldenström’s macroglobulinaemiaBoth criteria must be met:
IgM monoclonal gammopathy and
10% bone marrow infiltration (usually intertrabecular) by lymphoplasmacytic cells (morphology/immunophenotype)1
IgM monoclonal gammopathy of undetermined significanceAll three criteria must be met:
Serum IgM monoclonal protein < 30 g/L
Bone marrow lymphoplasmacytic infiltration < 10%
No evidence of anemia, constitutional symptoms, hyperviscosity, lymphadenopathy or hepatosplenomegaly
Smoldering Waldenström’s macroglobulinemiaBoth criteria must be met:
Serum IgM monoclonal protein > 30 g/L and/or bone marrow lymphoplasmacytic infiltration > 10%
No evidence of end-organ damage such as anemia, constitutional symptoms, hyperviscosity, lymphadenopathy or hepatosplenomegaly due to a lymphoplasma cell proliferative disorder